Nonalcoholic fatty liver disease and bariatric surgery - PubMed (original) (raw)
Review
Nonalcoholic fatty liver disease and bariatric surgery
Sindu Stephen et al. Expert Rev Gastroenterol Hepatol. 2012 Apr.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease worldwide. Treatment recommendations for NAFLD are aimed towards weight reduction, thereby reducing insulin resistance. Unfortunately, lifestyle modifications have not yielded long-term success, while durable weight loss is routinely achieved with bariatric surgery. This article reviews the effects of bariatric surgery on patients with NAFLD. In these patients, postsurgical evaluations of liver histology by repeat liver biopsy are hindered by the risk of the procedure and the inherent sample variability, which makes the impact of bariatric surgery on NAFLD difficult to quantify. In longitudinal studies of NAFLD, the biopsy-based evaluations should be augmented by repeated measurements of the noninvasive biomarkers that may provide an insight into the changes in the physiological state of the liver after bariatric or other types of interventions. Nevertheless, currently available tests are not able to provide this type of in-depth outcome measures for these patients.
Similar articles
- The impact of bariatric surgery on nonalcoholic steatohepatitis.
Rabl C, Campos GM. Rabl C, et al. Semin Liver Dis. 2012 Feb;32(1):80-91. doi: 10.1055/s-0032-1306428. Epub 2012 Mar 13. Semin Liver Dis. 2012. PMID: 22418890 Review. - Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.
Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R, Pigeyre M, Verkindt H, Dharancy S, Louvet A, Romon M, Pattou F. Mathurin P, et al. Gastroenterology. 2009 Aug;137(2):532-40. doi: 10.1053/j.gastro.2009.04.052. Epub 2009 May 4. Gastroenterology. 2009. PMID: 19409898 - Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
Tilg H, Moschen A. Tilg H, et al. Minerva Gastroenterol Dietol. 2010 Jun;56(2):159-67. Minerva Gastroenterol Dietol. 2010. PMID: 20485253 Review. - Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
Furuya CK Jr, de Oliveira CP, de Mello ES, Faintuch J, Raskovski A, Matsuda M, Vezozzo DC, Halpern A, Garrido AB Jr, Alves VA, Carrilho FJ. Furuya CK Jr, et al. J Gastroenterol Hepatol. 2007 Apr;22(4):510-4. doi: 10.1111/j.1440-1746.2007.04833.x. J Gastroenterol Hepatol. 2007. PMID: 17376042 - Effect of weight loss on nonalcoholic fatty liver disease.
Patel AA, Torres DM, Harrison SA. Patel AA, et al. J Clin Gastroenterol. 2009 Nov-Dec;43(10):970-4. doi: 10.1097/MCG.0b013e3181b57475. J Clin Gastroenterol. 2009. PMID: 19727004 Review.
Cited by
- Treatment options for alcoholic and non-alcoholic fatty liver disease: A review.
Singh S, Osna NA, Kharbanda KK. Singh S, et al. World J Gastroenterol. 2017 Sep 28;23(36):6549-6570. doi: 10.3748/wjg.v23.i36.6549. World J Gastroenterol. 2017. PMID: 29085205 Free PMC article. Review. - Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease.
Decaris ML, Emson CL, Li K, Gatmaitan M, Luo F, Cattin J, Nakamura C, Holmes WE, Angel TE, Peters MG, Turner SM, Hellerstein MK. Decaris ML, et al. PLoS One. 2015 Apr 24;10(4):e0123311. doi: 10.1371/journal.pone.0123311. eCollection 2015. PLoS One. 2015. PMID: 25909381 Free PMC article. - Knowledge-based identification of soluble biomarkers: hepatic fibrosis in NAFLD as an example.
Page S, Birerdinc A, Estep M, Stepanova M, Afendy A, Petricoin E, Younossi Z, Chandhoke V, Baranova A. Page S, et al. PLoS One. 2013;8(2):e56009. doi: 10.1371/journal.pone.0056009. Epub 2013 Feb 6. PLoS One. 2013. PMID: 23405244 Free PMC article. - HbA1c may contribute to the development of non-alcoholic fatty liver disease even at normal-range levels.
Chen C, Zhu Z, Mao Y, Xu Y, Du J, Tang X, Cao H. Chen C, et al. Biosci Rep. 2020 Jan 31;40(1):BSR20193996. doi: 10.1042/BSR20193996. Biosci Rep. 2020. PMID: 31940026 Free PMC article. - Role of peroxisome proliferator-activated receptors in non-alcoholic fatty liver disease inflammation.
Silva AKS, Peixoto CA. Silva AKS, et al. Cell Mol Life Sci. 2018 Aug;75(16):2951-2961. doi: 10.1007/s00018-018-2838-4. Epub 2018 May 22. Cell Mol Life Sci. 2018. PMID: 29789866 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical